Home Cart 0 Sign in  

[ CAS No. 226070-47-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 226070-47-9
Chemical Structure| 226070-47-9
Structure of 226070-47-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 226070-47-9 ]

Related Doc. of [ 226070-47-9 ]

Alternatived Products of [ 226070-47-9 ]

Product Details of [ 226070-47-9 ]

CAS No. :226070-47-9 MDL No. :MFCD10700132
Formula : C13H17NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :QLHANXZSEULFFM-UHFFFAOYSA-N
M.W : 235.28 Pubchem ID :18630963
Synonyms :

Safety of [ 226070-47-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 226070-47-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 226070-47-9 ]
  • Downstream synthetic route of [ 226070-47-9 ]

[ 226070-47-9 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 24424-99-5 ]
  • [ 226070-47-9 ]
YieldReaction ConditionsOperation in experiment
51%
Stage #1: With sodium hydrogencarbonate In water at 3℃; for 0.25 h;
Stage #2: at 3 - 20℃; for 4 h;
5-Hydroxy-1,3-dihydro-isoindole-2-carboxylic acid tert-butyl esterSolid NaHCO3 (70.35 g, 0.8375 mol, 2.5 equiv) was added slowly portion wise to a near solution of crude 2,3-Dihydro-1 H-isoindol-5-ol hydrobromide (72.02 g, 0.335 mol) in H2O (750 mL) at ~3 0C. When addition was complete, the reaction mixture was stirred for 15 min 5 then diluted with THF (500 mL). A solution of BoC2O (73.03 g, 0.335 mol) in THF (200 mL) was added over 0.5 h at 3-4 0C. The brown reaction mixture was stirred at ~3 0C for 0.5 h then allowed to warm to room temperature and stirred for 3 h. The reaction mixture was diluted with EtOAc (1.5 L) and the organic solution washed with brine, dried (Na2SO4) and the solvent removed in vacuo giving a dark brown solid. The crude product was absorbed onto 0 silica gel using DCM and added to a column of silica gel (2 kg) packed in heptane. Elution with heptane to.heptane/EtOAc (3:1) gave a light brown solid that was slurried in heptane, filtered, washed with heptane and dried to give 39.82 g (51percent) of 5-Hydroxy-1 ,3-dihydro- isoindole-2-carboxylic acid tert-butyl ester as an off-white solid. MS: APCI: M-C4H9+1: 180.0 (179.0).
Reference: [1] Patent: WO2008/20306, 2008, A2, . Location in patent: Page/Page column 22; 24
  • 2
  • [ 50727-06-5 ]
  • [ 24424-99-5 ]
  • [ 226070-47-9 ]
YieldReaction ConditionsOperation in experiment
22%
Stage #1: With borane-THF In tetrahydrofuran at -5 - 80℃; for 19 h;
Stage #2: With hydrogenchloride In methanol; water at 0 - 80℃; for 3 h;
Stage #3: With triethylamine In methanol; water at 22℃; for 0.5 h;
Preparation of 2,3-dihydro-5-hydroxy-1H-isoindole (7); tert-Butyl 5-hydroxy-1,3-dihydroisoindole-2-carboxylate (6): 750 ml of a 1M borane/THF solution are added dropwise to 20.4 g (125 mmol) of hydroxyisoindole-1,3-dione in 300 ml of THF (dry) at -5° C. over a period of 60 min. The mixture is subsequently stirred for 2 h at 22° C. and then for 16 h at 80° C. The mixture is then cooled to 0° C., before 100 ml of methanol (exothermic.) and 100 ml of 2M hydrochloric acid are slowly added. The resultant mixture is stirred for 3 h at 80° C., cooled to 22° C., and 100 ml of water are added. The aqueous solution is extracted three times with 150 ml of dichloromethane each time. 27.8 g (125 mmol) of di-tert-butyl dicarbonate and 12.6 g (125 mmol) of triethylamine are then added to this aqueous solution, and the mixture is then stirred for 30 min at 22° C. The mixture is subsequently extracted three times with 100 ml of dichloromethane each time, the organic phases are dried over sodium sulfate, filtered, and the filtrate is evaporated to dryness in vacuo. Trituration with petroleum ether gives 6.7 g (22percent) of pale-beige crystals; 1H-NMR (500 MHz, DMSO-d6/TFA-d1, 90° C.): δ [ppm] 7.093 (m, 1H), 6.709 (m, 2H), 4.486 (m, 4H), 1.457 (s, 9H); MW 235.3.
Reference: [1] Patent: US2010/311745, 2010, A1, . Location in patent: Page/Page column 18
  • 3
  • [ 201940-08-1 ]
  • [ 226070-47-9 ]
Reference: [1] Journal of the American Chemical Society, 2016, vol. 138, # 41, p. 13493 - 13496
[2] Angewandte Chemie - International Edition, 2018, vol. 57, # 7, p. 1968 - 1972[3] Angew. Chem., 2018, vol. 130, p. 1986 - 1990,5
  • 4
  • [ 24424-99-5 ]
  • [ 54544-67-1 ]
  • [ 226070-47-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 5, p. 685 - 688
[2] Patent: US2010/256137, 2010, A1, . Location in patent: Page/Page column 18
  • 5
  • [ 127168-88-1 ]
  • [ 226070-47-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 5, p. 685 - 688
Same Skeleton Products
Historical Records